Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies.
Merkies ISJ, van Schaik IN, Léger JM, Bril V, van Geloven N, Hartung HP, Lewis RA, Sobue G, Lawo JP, Durn BL, Cornblath DR, De Bleecker JL, Sommer C, Robberecht W, Saarela M, Kamienowski J, Stelmasiak Z, Tackenberg B, Mielke O; PRIMA Trial Investigators and the PATH Study Group. Merkies ISJ, et al. Among authors: saarela m. J Peripher Nerv Syst. 2019 Mar;24(1):48-55. doi: 10.1111/jns.12302. Epub 2019 Feb 15. J Peripher Nerv Syst. 2019. PMID: 30672091 Free PMC article. Clinical Trial.
Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study).
Léger JM, De Bleecker JL, Sommer C, Robberecht W, Saarela M, Kamienowski J, Stelmasiak Z, Mielke O, Tackenberg B, Shebl A, Bauhofer A, Zenker O, Merkies IS; PRIMA study investigators. Léger JM, et al. Among authors: saarela m. J Peripher Nerv Syst. 2013 Jun;18(2):130-40. doi: 10.1111/jns5.12017. J Peripher Nerv Syst. 2013. PMID: 23781960 Free PMC article. Clinical Trial.
Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial.
Merkies ISJ, Lawo JP, Edelman JM, De Bleecker JL, Sommer C, Robberecht W, Saarela M, Kamienowski J, Stelmasiak Z, Mielke O, Tackenberg B, Léger JM; PRIMA trial investigators. Merkies ISJ, et al. Among authors: saarela m. J Peripher Nerv Syst. 2017 Jun;22(2):149-152. doi: 10.1111/jns.12204. J Peripher Nerv Syst. 2017. PMID: 28594116 Free PMC article. Clinical Trial. No abstract available.
Assessment of the feed additive consisting of Lentilactobacillus buchneriATCC PTA-2494 for all animal species for the renewal of its authorisation (Pioneer Hi-Bred International, Inc.).
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP); Bampidis V, Azimonti G, Bastos ML, Christensen H, Durjava M, Dusemund B, Kouba M, López-Alonso M, López Puente S, Marcon F, Mayo B, Pechová A, Petkova M, Ramos F, Villa RE, Woutersen R, Saarela M, Alija-Novo N, Anguita M, Bozzi Cionci N, Brozzi R, García-Cazorla Y, Innocenti ML, Revez J. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al. Among authors: saarela m. EFSA J. 2024 May 23;22(5):e8786. doi: 10.2903/j.efsa.2024.8786. eCollection 2024 May. EFSA J. 2024. PMID: 38784843 Free PMC article.
Assessment of the feed additive consisting of Lentilactobacillus buchneriATCC PTA-6138 for all animal species for the renewal of its authorisation (Pioneer Hi-Bred International, Inc.).
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP); Bampidis V, Azimonti G, Bastos ML, Christensen H, Durjava M, Dusemund B, Kouba M, López-Alonso M, López Puente S, Marcon F, Mayo B, Pechová A, Petkova M, Ramos F, Villa RE, Woutersen R, Saarela M, Alija-Novo N, Anguita M, Bozzi Cionci N, Brozzi R, García-Cazorla Y, Innocenti ML, Revez J. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al. Among authors: saarela m. EFSA J. 2024 May 23;22(5):e8787. doi: 10.2903/j.efsa.2024.8787. eCollection 2024 May. EFSA J. 2024. PMID: 38784842 Free PMC article.
Assessment of the feed additive consisting of Limosilactobacillus fermentumNCIMB 30169 for all animal species for the renewal of its authorisation (Microferm Ltd.).
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP); Bampidis V, Azimonti G, Bastos ML, Christensen H, Durjava M, Dusemund B, Kouba M, López-Alonso M, López Puente S, Marcon F, Mayo B, Pechová A, Petkova M, Ramos F, Villa RE, Woutersen R, Saarela M, Anguita M, Bozzi Cionci N, Brozzi R, García-Cazorla Y, Innocenti ML, Revez J. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al. Among authors: saarela m. EFSA J. 2024 May 23;22(5):e8794. doi: 10.2903/j.efsa.2024.8794. eCollection 2024 May. EFSA J. 2024. PMID: 38784841 Free PMC article.
Safety and efficacy of a feed additive consisting of 6-phytase produced with Trichoderma reesei (CBS 126897) (Quantum® Blue) for fin fish (ROAL Oy).
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP); Bampidis V, Azimonti G, Bastos ML, Christensen H, Dusemund B, Durjava M, Kouba M, López-Alonso M, López Puente S, Marcon F, Mayo B, Pechová A, Petkova M, Ramos F, Villa RE, Woutersen R, Saarela M, Anguita M, Bozzi Cionci N, Brozzi R, Galobart J, García-Cazorla Y, Innocenti ML, Ortuño J, Pettenati E, Pizzo F, Vettori MV, Amaduzzi A. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al. Among authors: saarela m. EFSA J. 2024 May 15;22(5):e8709. doi: 10.2903/j.efsa.2024.8709. eCollection 2024 May. EFSA J. 2024. PMID: 38751506 Free PMC article.
406 results